Seres Therapeutics's total assets for Q3 2025 were $143.47M, a decrease of -0.23% from the previous quarter. DE:1S90 total liabilities were $99.78M for the fiscal quarter, a -9.99% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.